SK BIOPHARMACEUTICALS earnings per share and revenue

326030 earnings per share for the last quarter are 267.84 KRW whereas the estimation was 267.84 KRW which accounts for 0.00% surprise. Company revenue for the same period amounts to 144.40 B KRW despite the estimated figure of 155.35 B KRW. Estimated earnings per share for the next quarter are 314.45 KRW, and revenue is expected to reach 166.50 B KRW. Also watch annual changes over time to get a bigger picture of 326030 earnings per share and revenue dynamics.